Luye claims its first FDA approval, for bi-weekly schizophrenia drug
pharmaphorum
JANUARY 16, 2023
China’s Luye Pharma has claimed its first FDA approval, getting a green light for Rykindo, an injectable formulation of the antipsychotic risperidone given every two weeks. ” The post Luye claims its first FDA approval, for bi-weekly schizophrenia drug appeared first on.
Let's personalize your content